Utah Medical Products Form 8-K September 13, 2005

0001096906-05-000516.txt : 20050913 0001096906-05-000516.hdr.sgml : 20050913 20050913101402 ACCESSION NUMBER: 0001096906-05-000516 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050913 ITEM INFORMATION: Other Events FILED AS OF DATE: 20050913 DATE AS OF CHANGE: 20050913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 051081271 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utahmed8k091305.htm UTAH MEDICAL PRODUCTS FORM 8-K SEPTEMBER 13, 2005 Utah Medical Products Form 8-K September 13, 2005

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 13, 2005

Commission File No. 0-11178

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

UTAH	87-0342734
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

7043 South 300 West

Midvale, Utah 84047

Address of principal executive offices

Registrant's telephone number: (801) 566-1200

ITEM 8.01 OTHER EVENTS

On September 13, 2005, Utah Medical Products, Inc. issued a press release announcing that its FDA trial date has been set. A copy of the press release is attached hereto as Exhibit 99.1

SIGNATURES

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UTAH MEDICAL PRODUCTS, INC.
	REGISTRANT


Date: 9/13/05	By:	/s/ Kevin L. Cornwell
		Kevin L. Cornwell
		CEO

EXHIBIT INDEX

Index Number	Description

99.1	Press release issued September 13, 2005: Utah Medical Products, Inc.: FDA Trail Date Set

EX-99.1 2 utahmed8k091305ex99-1.htm EXHIBIT 99.1 Exhibit 99.1

EXHIBIT 99.1

Salt Lake City, Utah - The trial of the lawsuit filed in August 2004 on behalf of the U.S. Food and Drug Administration (FDA) alleging Quality System Regulation (QSR) violations by Utah Medical Products, Inc. (Nasdaq: UTMD) is scheduled to begin on September 26, 2005 in the U.S. District Court in Salt Lake City, Judge Bruce S. Jenkins presiding.

The trial will focus on UTMD’s compliance with the QSR. On September 19, 2005, lawyers for UTMD will file a pretrial brief and proposed findings of fact and conclusions of law for the Court to consider. The Company will provide a copy of UTMD’s pretrial brief and proposed findings of fact and conclusions of law to investors who request it by calling Paul Richins at (800) 533-4984 or (801) 566-1200.

UTMD’s administrative claim for damages concerning alleged FDA misconduct was submitted to the Department of Health and Human Services in July. The FDA has until January 8, 2006 to consider UTMD’s claim for damages. Accordingly, UTMD’s damages claim will not be addressed at the currently scheduled trial.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures, assembles and markets a broad range of well-established, safe and effective, disposable and reusable specialty medical devices.